The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

Generic filters
Generic filters






Deputy Director, Clinical and Population Health
Baker Heart and Diabetes Institute

Professor Jonathan Shaw is one of the world leaders in the epidemiology of diabetes. He has published over 250 peer-reviewed papers, has over 2,700 citations annually, and was one of only seven Australians listed in the Clinical Medicine section of the Thomson Reuters “The World’s Most Influential Scientific Minds 2014”. His work has ranged from discovering risk factors for diabetes to developing clinical guidelines and a diabetes risk screening tool. His frequent media appearances contribute to the public understanding of science, and he has taken a leading role in academic and clinical aspects of Indigenous health as it relates to diabetes.

Executive Director & CEO
Neuroscience Research Australia (NeuRA)

Professor Peter Schofield is Executive Director and CEO of NeuRA – Neuroscience Research Australia – one of Australia’s leading independent neuroscience research centres, and Professor of Medicine at UNSW. His research has fundamentally altered the understanding of neurotransmitter signaling and has identified the role of genes that lead to neurodegenerative and psychiatric disorders such as Alzheimer’s disease and bipolar disorder. He has published over 290 papers. He has taken leadership roles in professional organizations including ASMR, Research Australia, on government committees and in the development of NeuRA’s research program that addresses clinical and laboratory research addressing both neurological and psychiatric disorders.

Laureate Professor, Paediatric Neurology Research
The University of Melbourne & Florey Institute of Neuroscience and Mental Health
Immediate Past President

Professor Ingrid Scheffer is a physician-scientist whose work as a paediatric neurologist and epileptologist at the University of Melbourne and Florey Institute has led the field of epilepsy genetics over more than 20 years, in collaboration with Professor Samuel Berkovic and molecular geneticists. This resulted in identification of the first epilepsy gene and many more genes subsequently. Professor Scheffer has described many novel epilepsy syndromes and performed genotype-phenotype correlation. She recently played a key role in the first major reclassification of the epilepsies in two decades as Chair of the International League Against Epilepsy Commission for Classification and Terminology.

She obtained her medical degree from Monash University and her PhD from the University of Melbourne for which she received the Chancellor’s Award. She trained in paediatrics at the Royal Children’s Hospital in Melbourne, paediatric neurology at The Great Ormond Street Hospital for Sick Children, London UK, and epileptology at the Austin Hospital. In her PhD on the genetics of the epilepsies, she described four novel epilepsy syndromes which served as the basis for gene discovery.

She has received many awards: 2007 American Epilepsy Society Clinical Research Recognition Award, 2009 RACP Eric Susman Prize, 2013 GSK Award for Research Excellence, ILAE Ambassador for Epilepsy Award, 2013 Australian Neuroscience Medallion, 2013 Emil Becker Prize for child neurology and the L’Oreal-UNESCO Women in Science Laureate for the Asia-Pacific region for 2012. In 2014, she was elected as a Fellow of the Australian Academy of Sciences. She was awarded the Order of Australia in 2014 for “distinguished service to medicine in the field of paediatric neurology as a clinician, academic and mentor, and to research into the identification of epilepsy syndromes and genes”. Together with Professor Sam Berkovic, she was awarded the 2014 Prime Minister’s Prize for Science.

Head of Biomedical Imaging and Prostate Cancer Models
Australian Prostate Cancer Research Centre – Queensland, Queensland University of Technology

Highly creative scientist, Professor Pam Russell, initiated cyclophosphamide therapy for autoimmunity and is internationally recognized for generating urological cancer models for study. She directed the Oncology Research Centre, Prince of Wales Hospital, Sydney for 17 years, published 200 papers, patents, procured $34m in grants and mentored postgraduates and 30 postdoctoral fellows. Discoveries include antibodies to diagnose and image prostate cancer and innovative gene therapy. Regularly invited to collaborate, present worldwide, contribute book chapters, edit specialist journals, review and join global scientific committees, she founded the Prostate Cancer Foundation of Australia, interacting with public groups. Awards include Australian honours for research contributions.


Vale Pamela Russell, February 2022.

Professor of Surgery, Monash University; Senior Neurosurgeon, Alfred Hospital
Monash University

Professor Jeffrey Rosenfeld is an Australian and international leader in neurosurgery and military surgery. He has conducted seminal research in brain and spine injury, paediatric epilepsy, stem cell applications and bionic vision. He is Founding Director of the Monash Institute of Medical Engineering (MIME) and is a champion of interdisciplinary research. He is Professor of Surgery, Monash University; Director, Neurosurgery, Alfred Hospital; and has Adjunct Professorships in USA and PNG. He has had extensive engagement in developing countries and longstanding community involvement in Australia. His many appointments include Major General, the Australian Defence Force (ADF) and immediate past Surgeon General, ADFReserves.

Head of Clinical Translation
Clinical Translation Centre, The Walter and Eliza Hall Institute of Medical Research

Professor Andrew Roberts is a world-leader in translational research into blood cancers. His laboratory work has discovered the function of key proteins in blood cells, and guided the development of new drugs to target BCL2. His clinical trial research has led to advances in therapy for patients undergoing donor stem cell transplants, and pioneered targeted therapies for incurable blood cancers. He champions health and medical science through service to NHMRC, as chair of the Cancer Council Victoria, as a director of a national clinical trials co-operative group and as a member of the Pharmaceutical Benefits Advisory Committee.

Director of Therapeutics Research Centre
School of Medicine, University of Queensland

Professor Roberts is a pharmacist who, during 40 years as a practitioner, academic, and NHMRC SPRF, has focussed on medical research. His outputs include: H-index of 48, 6 books, 480 papers/chapters; 105 invited international talks; >$38m grants from NHMRC, ARC etc. He has been an APSA President, ASCEPT Councillor, University Head of School, University Research Centre Director, Director/ Chair Education Board for Australian College of Pharmacy and Chairman of TGA’s Australian Drug Evaluation Committee (Pharm) Committee. He has received the highest awards by his professional organisations: APSA Medal; ASCEPT Michael Rand Medal and Fellowship of the Australian College of Pharmacy.

Matthew Flinders Distinguished Professor of Biomedical Engineering / Deputy Dean, Computer Science, Engineering & Mathematics
Flinders University

Bridging the divide between research and industry, Professor Karen Reynolds is considered as one of Australia’s leading researchers in biomedical engineering. She is motivated by her passion to make a practical difference, and uses her experience and expertise together with her wide network of industry and clinical contacts to bring together multiple stakeholders to develop innovative solutions to healthcare problems. Karen has provided exceptional leadership within the University, within the Profession, and within the Industry. She has also provided inspiration and motivation to her colleagues and peers and to generations of students across the tertiary and secondary sectors.

Acting Deputy Vice-Chancellor (Research)
Griffith University

Professor Sheena Reilly has generated a substantial body of original research in childhood communication disorders and swallowing problems, as displayed by her publications and their impact on clinical practice in this discipline. Sheena’s Early Language in Victoria Study has rapidly become internationally significant in the evolution of language impairment. It’s the only specialist cohort study with population data from infancy through to the school years. Sheena’s strengths as a teacher, clinician and researcher, together with the close partnership between the University of Melbourne, the RCH and MCRI, enable her to play a key role in the integration of research into clinical practice.

Dean, Faculty of Health Sciences and Professor of Physiotherapy
The University of Sydney

Professor Refshauge is an outstanding musculoskeletal researcher, of high international standing. Her research in back and neck pain has changed practice among educators and clinicians. She developed new care models and stimulated vigorous international debate about neck manipulation. She is a highly sought after keynote speaker for prestigious international conferences, and contributor to book chapters, and best practice guidelines. Her visionary approach to health delivery has led to collaborations among leaders of education, government and health to further health research. Her passion for mentoring the next generation of researchers is recognized by three awards for exceptional mentorship.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2022
Newly elected Fellows of 2022 are inducted at the Annual Meeting.

Late September 2022-November 2022
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2022
Nominations allocated to Selection Committees.

January – April 2023
Referees’ reports sought.

Early May 2023
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2023
Council meets to finalise recommendations.

Late July 2023
Full Fellowship invited to comment on recommended new fellows.

August 2023
Election results are shared with proposers and candidates (under embargo).

October 2023
Newly elected Fellows of 2023 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.